Troy E. Wilson - 02 Jan 2024 Form 4 Insider Report for Kura Oncology, Inc. (KURA)

Role
President and CEO, Director
Signature
Teresa Bair, Attorney-in-fact for Troy E. Wilson
Issuer symbol
KURA
Transactions as of
02 Jan 2024
Transactions value $
$0
Form type
4
Filing time
04 Jan 2024, 16:06:02 UTC
Previous filing
14 Dec 2023
Next filing
26 Jan 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KURA Option to purchase common stock Award $0 +560K $0.00 560K 02 Jan 2024 Common Stock 560K $15.36 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option vests in 48 equal monthly installments commencing on the grant date.